Imaging

World-leading imaging centre of excellence opened in Glasgow

30 March 2017 | By Niamh Marriott (Drug Target Review)

The University of Glasgow has officially opened its new £32M Imaging Centre of Excellence (ICE).

Application Note: IDEA Bio-Medical offers a new feature for spatio-temporal analysis of rare events measures, using high-content microscopy

15 March 2017 | By IDEA Bio-Medical Ltd.

IDEA Bio-Medical offers a new feature for spatial detection and characterisation of temporal kinetics of rare events using its advanced HCS system, WiScan® Hermes...

Application Note: Exploration of microbial communities using the Thermo Scientific Varioskan LUX Multimode Reader and the Invitrogen EVOS FL Cell Imaging System

15 March 2017 | By Thermo Fisher Scientfic

This application note demonstrates the feasibility of combining the Thermo Scientific™ Varioskan™ LUX multimode reader and Invitrogen™ EVOS™ FL Cell Imaging System for the fluorescence-based quantification and imaging of complex biological systems, without requiring separate assay optimisation...

3D visualisation of the pancreas – new tool in diabetes research

15 March 2017 | By Niamh Marriott (Drug Target Review)

Umeå researchers have created datasets that map the three-dimensional distribution and volume of the insulin-producing cells in the pancreas.

Biomarkers In-Depth Focus 2017

15 March 2017 | By Caleb Roberts, Francesco Gatto, Jens Nielsen, John C Waterton, Juliana Maynard, Paul D Hockings

Drug developers sometimes think of imaging as an emerging discipline. But John Waterton, Paul Hockings, Juliana Maynard and Caleb Roberts explain how imaging biomarkers are transforming drug development. Francesco Gatto and Jens Nielsen, from the Chalmers University of Technology in Sweden, discuss moving towards systems biomarkers for cancer diagnosis...

IDEA Bio-Medical Ltd.

Drug Target Review – Issue #1 2017

9 March 2017 | By Drug Target Review

Included in this issue: Importance of building patient trust; Vaccines & Immunology; Oncology; Assays; Biomarkers; and Antibodies...

How imaging biomarkers are transforming drug development

15 January 2017 | By Caleb Roberts, John Waterton, Juliana Maynard, Paul Hockings

Drug developers sometimes think of imaging as an emerging discipline, full of esoteric technologies of marginal relevance to real-world clinical drug development. In fact, the opposite is true: imaging measurements (imaging biomarkers) are used daily in drug development and in personalised medicine. They assess target engagement and receptor occupancy in…

High-throughput screening platforms incorporating physiologically relevant 3-D models

8 January 2017 | By Anton Simeonov, Madhu Lal-Nag

Two-dimensional monolayer cell proliferation assays for cancer drug discovery have enabled large-scale screens. But they represent a simplified view of oncogenes or tumour suppressor genes as the genetic drivers of cancer cell proliferation.

Researchers develop new retinal imaging technique

3 January 2017 | By Niamh Marriott (Drug Target Review)

Researchers at the University of Rochester Medical Centre have developed a new imaging technique to better assess eye health and potential disease.

PathHunter® Protein Translocation Assays

21 December 2016 | By DiscoverX Corporation

The movement of proteins between cellular compartments is essential for their specific biological role and the function of the cell...

Diabetic research suggests purslane herb extract mimics insulin

20 December 2016 | By Niamh Marriott (Drug Target Review)

A new study has confirmed the anti-diabetic properties of the purslane herb extract Portulaca oleracea L.

Molecular Devices

€3.3 million to improve medical imaging detail tenfold

3 November 2016 | By Niamh Louise Marriott, Digital Content Producer

A recent investment of €3.3 million will allow researchers to improve the detail of medical imaging ten times over, which will allow for tumour scanning...

Charles River Laboratories acquires Agilux Laboratories, Inc.

13 October 2016 | By Charles River Laboratories

Enhances Charles River’s early-stage capabilities in bioanalytical services...